NIH SBIR Phase II
Supports United States biomedical small businesses advancing successful feasibility work into scale-up development.
NIH SBIR Phase II awards provide non-dilutive grant funding for small businesses to continue and scale the R&D work initiated under a Phase I award, with the goal of advancing innovations toward commercialization. The budget cap for Phase II is $2,153,927 for a project period of one to three years. Phase II applicants must have completed a Phase I award (or qualify for Direct-to-Phase II if feasib…
Continuation and scale-up of Phase I biomedical feasibility R&D toward commercialization, across all 24 participating NIH Institutes and Centers.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline